Authors: Tano, Benoit; Pathak, Dev; Hoffmann, Stephen

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 3, Number 6, December 2003 , pp. 741-747(7)

Publisher: Expert Reviews

Abstract:

The National Heart, Lung and Blood Institute guidelines for the treatment of asthma suggest that inhaled corticosteroids, with the addition of a long-acting bronchodilator, may be the most effective long-term control medication for asthma. Five inhaled corticosteroids are approved for use in the USA, including beclomethasone dipropionate, budesonide, flunisolide, triamcinolone acetonide and fluticasone propionate. Fluticasone propionate (Flixotide^®) and the long-acting β2 agonist salmeterol (Serevent^®), are now available in the USA together in an easy to use dry powder inhaler Advair^®. The cost-effectiveness of this combination in the treatment of persistent asthma is reviewed. This review evaluates all the cost-effectiveness studies comparing fluticasone propionate and salmeterol from two separate inhalers or one single inhaler available in the literature. Cost-effectiveness was compared with inhaled corticosteroids alone, leukotriene receptor antagonists and other combination therapies in patients with persistent asthma.

Keywords: advair; asthma; cost-effectiveness; healthcare

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737167.3.6.741

Publication date: 2003-12-01

More about this publication?

• Expert Review of Pharmacoeconomics & Outcomes Research provides expert commentary on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Economics ,  Pharmacology
• By this author: Tano, Benoit ;  Pathak, Dev ;  Hoffmann, Stephen

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers